Ahn-Gook, EffRx sales and marketing update

EffRx granted Ahn-Gook exclusive rights to develop and commercialize osteoporosis product Binosto alendronate in South Korea. Ahn-Gook anticipates approval of the alendronate effervescent and its subsequent launch in South Korea next year. FDA approved the product last year to treat osteoporosis. EffRx declined to disclose additional details (see BioCentury, April 30, 2012). ...